FDA Approves Labeling Changes for DEB Gene Therapy



The indication has been expanded to include use in newborns and allows patients and caregivers to apply the treatment at home.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/dystrophic-epidermolysis-bullosa-fda-approves-labeling-2025a1000oip?src=rss

Author :

Publish date : 2025-09-16 18:49:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version